Drug Shortage Report for CODEINE CONTIN 50MG CONTROLLED RELEASE TAB

Last updated on 2017-07-13 History
Report ID 13399
Drug Identification Number 02230302
Brand name CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Common or Proper name codeine controlled release tablets
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) CODEINE
Strength(s) 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60s
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-06-20
Actual start date 2017-06-20
Estimated end date 2017-06-30
Actual end date 2017-07-12
Shortage status Resolved
Updated date 2017-07-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-07-13 English Compare
v6 2017-07-12 French Compare
v5 2017-07-12 English Compare
v4 2017-07-12 English Compare
v3 2017-06-21 English Compare
v2 2017-06-20 French Compare
v1 2017-06-20 English Compare

Showing 1 to 7 of 7